Cited 0 times in 
Cited 0 times in 
Relacorilant and Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer (ROSELLA): An Open-label, Randomized, Controlled, Phase 3 Trial
https://orcid.org/0000-0003-0297-3116Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.